IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ODICINO, Franco Edoardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.722
EU - Europa 5.213
AS - Asia 4.335
SA - Sud America 818
AF - Africa 130
OC - Oceania 66
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 1
Totale 19.290
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.520
IT - Italia 2.009
SG - Singapore 1.430
CN - Cina 1.308
BR - Brasile 690
UA - Ucraina 647
HK - Hong Kong 550
PL - Polonia 500
DE - Germania 483
GB - Regno Unito 322
FI - Finlandia 269
VN - Vietnam 257
TR - Turchia 204
RU - Federazione Russa 190
IN - India 155
CH - Svizzera 143
IE - Irlanda 142
CA - Canada 116
FR - Francia 104
ID - Indonesia 79
ES - Italia 71
BD - Bangladesh 69
SE - Svezia 65
AU - Australia 53
JP - Giappone 53
MX - Messico 53
AR - Argentina 52
NL - Olanda 52
EE - Estonia 49
ZA - Sudafrica 45
IQ - Iraq 41
SA - Arabia Saudita 31
AT - Austria 20
EC - Ecuador 18
LT - Lituania 18
MY - Malesia 18
CZ - Repubblica Ceca 17
PK - Pakistan 15
PT - Portogallo 15
BE - Belgio 14
MA - Marocco 14
PE - Perù 14
LI - Liechtenstein 13
UZ - Uzbekistan 13
CL - Cile 12
AE - Emirati Arabi Uniti 11
EG - Egitto 11
JO - Giordania 11
NZ - Nuova Zelanda 11
KE - Kenya 10
LU - Lussemburgo 10
PH - Filippine 10
VE - Venezuela 10
AZ - Azerbaigian 9
BG - Bulgaria 9
CO - Colombia 9
DZ - Algeria 9
SK - Slovacchia (Repubblica Slovacca) 9
IL - Israele 8
JM - Giamaica 8
KZ - Kazakistan 8
MK - Macedonia 7
NP - Nepal 7
TN - Tunisia 7
AL - Albania 6
DK - Danimarca 6
ET - Etiopia 6
IR - Iran 6
KR - Corea 6
BH - Bahrain 5
EU - Europa 5
GH - Ghana 5
GR - Grecia 5
KG - Kirghizistan 5
NG - Nigeria 5
PY - Paraguay 5
BO - Bolivia 4
HN - Honduras 4
LK - Sri Lanka 4
MU - Mauritius 4
OM - Oman 4
RS - Serbia 4
TH - Thailandia 4
UG - Uganda 4
UY - Uruguay 4
BS - Bahamas 3
CR - Costa Rica 3
IS - Islanda 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BB - Barbados 2
BY - Bielorussia 2
CM - Camerun 2
GT - Guatemala 2
HR - Croazia 2
MG - Madagascar 2
MN - Mongolia 2
NO - Norvegia 2
SN - Senegal 2
Totale 19.263
Salva come PNG Salva come JPEG
Città #
Fairfield 913
Ashburn 864
Woodbridge 768
Singapore 649
Hong Kong 542
Houston 488
Warsaw 484
Jacksonville 444
Seattle 385
Wilmington 384
Chandler 344
Ann Arbor 338
Cambridge 322
Beijing 297
New York 287
Princeton 239
Los Angeles 221
Milan 174
Dearborn 168
Nanjing 158
Brescia 155
Dublin 141
Istanbul 140
Helsinki 136
Munich 127
Des Moines 100
The Dalles 100
Ho Chi Minh City 97
London 95
Moscow 90
Dallas 89
Zurich 87
Chicago 84
Rome 72
São Paulo 70
Redondo Beach 69
Buffalo 68
San Francisco 66
Shanghai 64
Boardman 57
Shenyang 51
Hanoi 50
Nanchang 49
Tallinn 49
Jakarta 47
Changsha 43
Hangzhou 42
Toronto 42
Hebei 40
San Diego 40
Tianjin 36
Denver 34
Stockholm 33
Tokyo 33
Turku 33
Jinan 32
Santa Clara 31
Chennai 30
Montreal 30
Frankfurt am Main 29
Jiaxing 29
Guangzhou 28
Johannesburg 27
Poplar 27
Brooklyn 26
Kunming 25
Nuremberg 23
Charlotte 22
Romola 22
Melbourne 21
Dong Ket 20
Boston 19
Lappeenranta 19
Orem 19
Phoenix 19
Pune 19
Turin 19
Washington 19
Belo Horizonte 18
Dhaka 18
Ankara 17
Paris 17
Mexico City 16
Pleasanton 16
Verona 16
Brasília 15
Hefei 15
Orange 15
Zhengzhou 15
Atlanta 14
Baghdad 14
Brussels 14
Dalmine 13
Lancaster 13
Rio de Janeiro 13
Amsterdam 12
Cedar Knolls 12
Haikou 12
Manchester 12
Mumbai 12
Totale 11.872
Salva come PNG Salva come JPEG
Nome #
Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study 2.460
Preeclampsia and late fetal growth restriction 340
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 330
Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients. 311
Claudin3 is localized outside the tight junctions in human carcinomas 275
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 265
Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients. 204
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 198
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. 188
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients 185
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 176
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 173
Role of 18F-FDG PET/CT in restaging and follow-up of patients with uterine sarcomas 169
RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients 168
Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management. 167
Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum 164
Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum 163
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 163
Consolidation therapies revisited: weekly paclitaxel 160
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition 157
Carcinoma of the Fallopian tube 155
Trefoil factor 3: a novel serum marker identified by gene expression profiling in highgrade endometrial carcinomas 154
Clinical and prognostic value of 18 F-FDG PET/CT in recurrent endometrial carcinoma 152
Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study 143
Carcinoma of the Fallopian tube 141
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 138
The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines 136
Adjuvant cisplatin-based chemotherapy for stage I and II ovarian cancer: a 7-year experience 134
Replacement therapy for breast cancer survivors. A pilot study 133
Kinase-driven metabolic signalling as a predictor of response to carboplatin-paclitaxel adjuvant treatment in advanced ovarian cancers 133
Early stage ovarian cancer: the Italian contribution to clinical research. An update 133
null 132
Parametrial endometriosis with ureteral involvement: A case report of a conservative approach without ureteral resection 132
Gestational trophoblastic diseases 131
Poor outcome of elderly patients with platinum-sensitive recurrent ovarian cancer: results from the SOCRATES retrospective study 130
Carcinoma of the corpus uteri 130
Role of HPV DNA, HPV mRNA and cytology in the follow-up of women treated for cervical dysplasia. 130
Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium 127
History of the FIGO cancer staging system 126
Interval debulking surgery in advanced epithelial ovarian cancer 126
LncRNAs as novel indicators of patients' prognosis in stage i epithelial ovarian cancer: A retrospective and multicentric study 126
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 126
Staging classification for cancer of the ovary, fallopian tube, and peritoneum 126
Carcinoma of the ovary. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. 125
Results of the 2006 Innsbruck International Consensus Conference on intraperitoneal chemotherapy in patients with ovarian cancer 125
Carcinoma of the fallopian tube. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. 124
Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients. 124
Morphologic and biologic studies on ten cases of verrucous carcinoma of the vulva supporting the theory of a discrete clinico-pathologic entity 124
Carcinoma of the corpus uteri 124
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 124
Hormone replacement therapy in breast cancer 123
Female Adnexal Tumor of Probable Wolffian Origin (FATWO): Case Report and Systematic Literature Review 122
New development of the FIGO staging system. 122
Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro 121
Carcinoma of the corpus uteri. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. 120
Systemic therapy for gynecological neoplasms: ovary, cervix and endometrium 120
Uterine sarcomas: a clinicopathologic study 120
Gestational trophoblastic diseases 120
Ultrasound examination in ovarian cancer patients. A comparison with second look laparotomy 120
Systemic therapy for gynecological neoplasms: ovary, cervix, and endometrium. 119
Five-year follow-up of placental involution after abdominal pregnancy 119
Carcinoma of the cervix uteri 119
Optimizing gemcitabine regimens in ovarian cancer. 118
Recurrent ovarian carcinoma: salvage treatment with platinum in patients responding to first-line platinum-based regimens 118
Staging of gynecologic malignancies 118
Revised FIGO staging for carcinoma of the cervix. 117
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 117
Carcinoma of the vagina 115
Management of endometrial cancer in Italy: a national survey endorsed by the Italian Society of Gynecologic Oncology 115
Crossover study with cisplatin or carboplatin in advanced ovarian cancer 114
Carcinoma of the ovary 114
Ovarial cancer: best timing and applications of debulking surgery 114
Identical TP53 mutations in pelvic carcinosarcomas and associated serous tubal intraepithelial carcinomas provide evidence of their clonal relationship 114
Carcinoma of the ovary 112
Which second-line treatment regimen should be used following relapse of platinum-sensitive ovarian cancer? 112
Carcinoma of the cervix uteri. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. 109
Improved Risk Prediction in Human Papillomavirus-Associated Endocervical Adenocarcinoma Through Assessment of Binary Silva Pattern-based Classification: An International Multicenter Retrospective Observational Study Led by the International Society of Gynecological Pathologists (ISGyP) 107
Investigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technology. 106
Carcinoma of the vagina 106
High-risk early-stage ovarian cancer. Randomized clinical trial comparing cisplatin plus cyclophosphamide versus whole abdominal radiotherapy 105
Carcinoma of the vulva 104
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 104
Cancer in women 103
Carcinoma of the cervix uteri 102
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 102
Integrated mutational landscape analysis of uterine leiomyosarcomas 97
Randomized study comparing chemotherapy plus radiotherapy versus radiotherapy alone in FIGO stage IIB-III cervical carcinoma. GONO (North-West Oncologic Cooperative Group) 97
Delaying surgery for patients with a previous SARS-CoV-2 infection 97
The treatment of progressive ovarian carcinoma with D-Trp-LHRH (Decapeptyl). Gruppo Oncologico Nord ovest (GONO) 93
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 92
Surgery of advanced malignant epithelial tumours of the ovary 91
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 91
The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features 89
Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma 88
Carcinoma of the vagina. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. 87
Chorionicity, birth weight discordance and neonatal morbidity in uncomplicated twin pregnancies delivered from 36 weeks 87
Early non-compliance to ERAS in gynecological open surgery for malignancies, and post-operative complications: a multicenter, prospective, observational, cohort study 86
A strange case of pleuritic pain in the third trimester of pregnancy 84
Clear cell degeneration associated with endometriosis of abdominal wall after cesarean section: A case report and systematic review of literature 84
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma 84
Totale 15.718
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.360
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.360
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.066 0 0 0 0 0 169 67 188 159 271 136 76
2021/20221.018 64 157 6 43 3 51 105 70 48 122 96 253
2022/20232.139 159 59 207 274 229 283 67 148 193 128 211 181
2023/20242.370 177 106 201 159 209 375 137 183 361 245 45 172
2024/20253.546 42 113 96 471 307 310 324 143 392 252 657 439
2025/20263.883 683 832 447 826 728 367 0 0 0 0 0 0
Totale 19.766